The COVID-19 pandemic presents us with a crisis of significant magnitude with no clear end in sight. There are numerous stressors affecting our healthcare system, economy, and social lives. In the midst of all this, we face new challenges to our mission to advance the field of IO, particularly in re
COVID19 poses a real threat to the well-being of our patients and we, as physician-scientists, are taking this threat seriously. In light of the available data, we act diligently to protect those most vulnerable in this situation: our cancer patients. The necessary measures to mitigate the spread of
Posted By: Constantinos T Sofocleous, MD, PhD, FSIR, FCIRSE
Fri Apr 24th, 2020
Cancer care during the pandemic requires assessment of several factors that are specific to each patient as well as the curve of the pandemic in a particular location and the infrastructure capabilities at the center offering care. As a general approach, we consider continuation of cancer care unles
The COVID-19 pandemic has greatly impacted the entire patient experience in interventional oncology at our institution. This goes beyond the known infected patients or those under investigation with the newly expected, necessary personal protective equipment (PPE) and safety precautions taken. It a
“Why are you bringing all these cancer patients into the hospital and putting us all at risk?” asked one of my non-IO colleagues. An undiagnosed COVID patient brought in that day for an extended procedure resulted in losing six staff to a week-long quarantine.